Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.

類似資料

• Use of luteinising hormone-releasing hormone agonist (leuprorelin) in advanced post-menopausal breast cancer: clinical and endocrine effects.
  著者:: Crighton, I. L., 等
  出版事項: (1989)
• Luteinising hormone releasing hormone agonist in women with endometriosis.
  著者:: Pring, D W, 等
  出版事項: (1983)
• Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630.
  著者:: Plowman, P. N., 等
  出版事項: (1986)
• Antithrombin III concentration, thrombosis, and treatment with luteinising hormone releasing hormone agonist in prostatic carcinoma.
  著者:: Varenhorst, E, 等
  出版事項: (1986)
• Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.
  著者:: Shaw, R W, 等
  出版事項: (1983)